UAE Enacts New Pharma Law to Boost Pharmaceutical Innovation “What can we learn from 2024’s biotech IPOs?” –  Adam Farlow chats to Fierce Biotech “Failure to prevent fraud”: Baker McKenzie breakfast briefing (15 January 2025) The French Political Crisis Leads the Pharmaceutical and Medical Device Industries Towards A Leap Into the Unknown for 2025 Extended Producer Responsibility for Pharmaceutical and Cosmetics Companies: Adoption of the Recast Urban Wastewater Treatment Directive